Artificial intelligence (AI) has been widely used in various medical fields, such as image diagnosis, pathological classification, selection of treatment schemes, and prognosis analysis. Especially in the image-aided diagnosis of tumors, the cooperation of human-computer interactions has become mature. However, the ethics of the application of AI as an emerging technology in clinical decision-making have not been fully supported, so the clinical decision support system (CDSS) based on AI technology has not fully realized human-computer interactions in clinical practice as the image-aided diagnosis system. The CDSS was currently used and promoted worldwide including Watson for Oncology, Chinese society of clinical oncology-artificial intelligence (CSCO AI) and so on. This paper summarized the applications and clarified the principle of AI in CDSS, analyzed the difficulties of AI in oncology decisions, and provided a reference scheme for the application of AI in oncology decisions in the future.
20 October 2022 in International Immunopharmacology
The tumor microenvironment (TME) can be regarded as a complex and dynamic microecosystem generated by the interactions of tumor cells, interstitial cells, the extracellular matrix, and their products and plays an important role in the occurrence, progression and metastasis of tumors. In a previous study, we constructed an IEO model (prI-, prE-, and pOst-metastatic niche) according to the chronological sequence of TME development. In this paper, to fill the theoretical gap in spatial heterogeneity in the TME, we defined an MCIB model (Metabolic, Circulatory, Immune, and microBial microenvironment). The MCIB model divides the TME into four subtypes that interact with each other in terms of mechanism, corresponding to the four major links of metabolic reprogramming, vascular remodeling, immune response, and microbial action, providing a new way to assess the TME. The combination of the MCIB model and IEO model comprehensively depicts the spatiotemporal evolution of the TME and can provide a theoretical basis for the combination of clinical targeted therapy, immunotherapy, and other comprehensive treatment modalities for tumors according to the combination and crosstalk of different subtypes in the MCIB model and provide a powerful research paradigm for tumor drug-resistance mechanisms and tumor biological behavior.
Under the standardized educational research model, a multicentre, randomized controlled educational research was conducted to compare the efficacy of the research, teaching and clinical integration (RTCi) and organ system-based curriculum (OSBC) teaching methods in the eight-year medical program. A total of 230 eight-year medical program participants from two clinical colleges signed informed consent for educational research, were randomly divided into the RTCi teaching group (N = 115) and the OSBC teaching group (N = 115) and underwent a one-year study under different teaching methods. The two groups were compared in terms of on-schedule graduation, the number of papers published per student, grade-weighted scores and objective structured clinical examination (OSCE) scores. The 230 participants were randomly divided into two groups. After one year of RTCi or OSBC teaching, the on-schedule graduation rate of the RTCi group was significantly higher than that of the OSBC group (90% vs. 70%, P = 0.006). The average number of papers published per student in the RTCi group was significantly greater than that in the OSBC group (1.3 vs. 0.7, P = 0.017). The study score of the RTCi group was greater than that of the OSBC group (85.6 vs. 85.2, P = 0.183), although the difference was not statistically significant. The OSCE score of the RTCi group was significantly greater than that of the OSBC group (93 vs. 90, P = 0.029). In the multicentre randomized controlled teaching study, compared with the OSBC teaching method, the RTCi teaching method significantly improved the on-schedule graduation rate, the number of published papers and the OSCE scores of participants. In terms of study scores, the RTCi teaching method outperformed the OSBC method, with no statistically significant difference. The RTCi teaching method is more conducive to the training and comprehensive development of eight-year medical program participants. In practice, medical education institutions could consider adopting the RTCi teaching method to enhance educational outcomes. Future research should further explore its long-term impact on the career development of medical graduates to strengthen its applicability and sustainability in eight-year medical program.
BackgroundExperimental biological research and clinical trials that relied on the healthcare system, access to public laboratory equipment, and adequate space were particularly affected by the COVID-19 pandemic and mobility restrictions. The study is to analyze the influence of COVID-19 on medical research by exploring the clinical trials and articles published by medical researchers worldwide during the COVID-19 pandemic.MethodsRoutinely conducted, deferred, and terminated clinical trial statistics from the Cancer Center of Tongji Hospital were collected during the COVID-19 pandemic. The number of global medical articles published in 2020 and those from the previous five years were analyzed according to the PubMed database. To conduct subgroup analyses, the articles were classified according to type and research field.Results The total number of publications per month in 2020 increased compared to the number of articles published in 2019. However, a decrease in the number of clinical trials was noted. Reviews and research papers increased by 7.28% and 20.60%, respectively. The number of clinical trial published decreased by 62.29%. The proportion of cancer-related publications (38.44% vs. 44.79%) decreased, whereas the proportion of immunology, pulmonology, and emergency publications (19.23% vs. 17.48%) increased. In the Cancer Center of the Tongji Hospital in Wuhan during the COVID-19 pandemic, of the 46 clinical trials analyzed, 37 (80.40%) were delayed, 8 (17.40%) were remote, and 1 (2.20%) was routine. Conclusions The COVID-19 pandemic had promoted the publication of medical research articles especially those related to the immunology, pulmonology, and emergency medicine. It had a pronounced negative impact on the execution and publication of clinical trials.